Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Breast Cancer Reports
Published in: Current Breast Cancer Reports 3/2018

01-09-2018 | Risk and Prevention (ME Wood, Section Editor)

Breast Reconstruction in the Setting of Surgical Prevention for Breast Cancer

Authors: Candice M. Leach, Meredith S. Collins

Published in: Current Breast Cancer Reports | Issue 3/2018

Login to get access

Abstract

Purpose of Review

Breast reconstruction after prophylactic mastectomy is an important component of the surgical prevention of breast cancer. Women who undergo bilateral prophylactic mastectomy view reconstruction as part of their treatment and the choice to pursue a contralateral mastectomy is influenced by the availability of reconstruction.

Recent Findings

There has been increased data available on both medical outcomes and patient-reported outcomes in reconstruction after mastectomy. This review of recent literature includes trends and outcomes with contralateral and bilateral prophylactic mastectomy with reconstruction, discussion of outcomes in implant and autologous tissue-based reconstruction, advancements in pre-pectoral implant placement, and new techniques of simultaneous mastectomy with reconstruction combined with gynecologic risk-reducing surgery.

Summary

Choice of reconstruction after prophylactic mastectomy is based on patient factors, availability of specialist services, and patient preference. Informed discussion with patients, plastic surgery, surgical oncology, and gynecology is necessary to determine the best option for each patient.
Literature
1.
2.
Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–9.CrossRefPubMed
3.
Desai S, Jena AB. Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie’s New York Times editorial. BMJ. 2016;355:i6357.CrossRefPubMedPubMedCentral
4.
Raphael J, Verma S, Hewitt P, Eisen A. The impact of Angelina Jolie (AJ)‘s story on genetic referral and testing at an academic cancer centre in Canada. J Genet Couns. 2016;25:1309–16.CrossRefPubMed
5.
Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996;77:2318–24.CrossRefPubMed
6.
7.
Buys SS, Sandbach J, Gammon A, et al. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017;123(10):1721–30.CrossRefPubMed
8.
Hunt KK, Euhus DM, Boughey JC, Chagpar AB, Feldman SM, Hansen NM, et al. Society of surgical oncology: breast disease working group statement on prophylactic (risk-reducing) mastectomy. Ann Surg Oncol. 2017;24(2):375–97.CrossRefPubMed
9.
Rebbeck TR, Freibel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA-1 and BRCA-2 mutation carriers: the PROSE study group. J Clin Oncol. 2004;22(6):1055–2062.CrossRefPubMed
10.
Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M. Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg. 2017;265(3):581–9.CrossRefPubMed
11.
Hoskin TL, Heikin TJ, Degnim AC, et al. Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy. Surgery. 2016;159(4):1199–209.CrossRefPubMed
12.
Agarwal S, Kidwell KM, Kraft CT, Kozlow JH, Sabel MS, Chung KC, et al. Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy. Plast Reconstr Surg. 2015;135(3):661–70.CrossRefPubMedPubMedCentral
13.
Ashfaq A, McGhan LJ, Pockaj BA, et al. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy. Ann Surg Oncol. 2014;21(9):2934–40.CrossRefPubMed
14.
Momoh AO, Cohen WA, Kidwell KM. Tradeofffs associated with contralateral prophylactic mastectomy in women choosing breast reconstruction. Ann Surg. 2017;266(1):158–64.CrossRefPubMedPubMedCentral
15.
Silva AK, Lapin B, Yao KA, Song DH, Sisco M. The effect of contralateral prophylactic mastectomy on perioperative complications in women undergoing immediate breast reconstruction: a NSQIP analysis. Ann Surg Oncol. 2015;22(11):3474–80.CrossRefPubMed
16.
Buchanan PJ, Abdulghani M, Waljee JF, Kozlow JH, Sabel MS, Newman LA, et al. An analysis of the decision made for contralateral prophylactic mastectomy and breast reconstruction. Plast Reconstr Surg. 2016;138(1):29–40.CrossRefPubMed
17.
Gopie JP, Hilhorst MT, Kleijne A, Timman R, Menke-Pluymers MBE, Hofer SOP, et al. Women’s motives to opt for either implant or DIEP-flap breast reconstruction. J Plast Reconstr Aesthet Surg. 2011;64(8):1062–7.CrossRefPubMed
18.
Semple J, Metcalfe K, Lynch HT, et al. International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers. Ann Surg Oncol. 2013;20(12):3817–22.CrossRefPubMedPubMedCentral
19.
Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE, et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. 2000;284(3):319–24.CrossRefPubMed
20.
McCarthy CM, Hamill JB, Hyungjin MK, et al. Impact of bilateral prophylactic mastectomy and immediate reconstruction on health-related quality of life in women at high risk for breast carcinoma: results of the mastectomy reconstruction outcomes consortium study. Ann Surg Oncol. 2017;24(9):2502–8.CrossRefPubMedPubMedCentral
21.
Metcalf KA, Semple JL, Narod SA. Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study. Plast Reconstr Surg. 2004;114(2):360–6.CrossRef
22.
Manning AT, Wood C, Eaton A, et al. Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance. Br J Surg. 2015;103(11):1354–9.CrossRef
23.
Jakub JW, Peled AW, Gray RJ, Greenup RA, Kiluk JV, Sacchini V, et al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: a multi-institutional study. JAMA Surg. 2018;153(2):123–9.CrossRefPubMed
24.
Murthy V, Chamberlain RS. Defining a place for nipple sparing mastectomy in modern breast care: an evidence based review. Breast J. 2013;19(6):571–81.CrossRefPubMed
25.
Spear SL, Willey SC, Feldman ED, Cocilovo C, Sidawy M, al-Attar A, et al. Nipple-sparing mastectomy for prophylactic and therapeutic indications. Plast Reconstr Surg. 2011;128(5):1005–14.CrossRefPubMed
26.
Dent BL, Miller JA, Eden DJ, et al. Tumor-to-nipple distance as a predictor of nipple involvement: expanding the inclusion criteria for nipple-sparing mastectomy. Plast Reconstr Surg. 2017;140(1):1e–8e.CrossRefPubMed
27.
Krajewski AC, Boughey JC, Degnim AC. Expanded indications and improved outcomes for nipple-sparing mastectomy over time. Ann Surg Oncol. 2015;22(10):3317–23.CrossRefPubMed
28.
Metcalfe KA, Cil TD, Semple JL, Li LDX, Bagher S, Zhong T, et al. Long-term psychosocial functioning in women with bilateral prophylactic mastectomy: does preservation of the nipple-areolar complex make a difference? Ann Surg Oncol. 2015;22(10):3324–30.CrossRefPubMed
29.
Bailey CR, Ogbuagu O, Baltodano PA. Quality-of-life outcomes improve with nipple-sparing mastectomy and breast reconstruction. Plast Reconstr Surg. 2017;140(2):219–26.CrossRefPubMed
30.
Wei CH, Scott AM, Price AN, Miller HC, Klassen AF, Jhanwar SM, et al. Psychological and sexual well-being following nipple-sparing mastectomy and reconstruction. Breast J. 2016;22(1):10–7.CrossRefPubMedPubMedCentral
31.
Platt J, Zhong T. Patient-centered breast reconstruction based on health-related quality-of-life evidence. Clin Plast Surg. 2018;45(1):137–43.CrossRefPubMed
32.
Spear SL, Rottman SJ, Seiboth LA, Hanna CM. Breast reconstruction using a staged nipple-sparing mastectomy following mastopexy or reduction. Plast Reconstr Surg. 2012;129(3):572–81.CrossRefPubMed
33.
Colwell AS, Tessler O, Lin AM, Liao E, Winograd J, Cetrulo CL, et al. Breast reconstruction following nipple-sparing mastectomy: predictors of complications, reconstruction outcomes, and 5-year trends. Plast Reconstr Surg. 2014;133(3):496–506.CrossRefPubMed
34.
Lam TC, Hsieh F, Boyages J. The effects of postmastectomy adjuvant radiotherapy on immediate two-stage prosthetic breast reconstruction: a systematic review. Plast Reconstr Surg. 2013;132(3):511–8.CrossRefPubMed
35.
Kronowitz SJ. Delayed-immediate breast reconstruction: technical and timing considerations. Plast Reconstr Surg. 2010;125(2):463–74.CrossRefPubMed
36.
Billig J, Jagsi R, Qi J, Hamill JB, Kim HM, Pusic AL, et al. Should immediate autologous breast reconstruction be considered in women who require postmastectomy radiation therapy? A prospective analysis of outcomes. Plast Reconstr Surg. 2017;139(6):1279–88.CrossRefPubMedPubMedCentral
37.
Khansa I, Wang D, Coriddi M, Tiwari P. Timing of Prophylactiv hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA 1 and BRCA 2 carriers. Microsurgery. 2014;34(4):271–6.CrossRefPubMed
38.
Khadim MF, Eastwood P, Price J, Morrison P, Khan K. Multidisciplinary one-stage risk-reducing gynaecological and breast surgery with immediate reconstruction in BRCA-gene carrier women. Eur J Surg Oncol. 2013;39(12):1346–50.CrossRefPubMed
39.
Hunsiner V, Marchac AC, Derder M, et al. A new strategy for prophylactic surgery in BRCA women: combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap. Ann Chir Plast Esthet. 2016;61(3):177–82.CrossRef
40.
Spear SL, Pennanen M, Barter J, Burke JB. Prophylactic mastectomy, oophorectomy, hysterectomy, and immediate transverse rectus abdominis muscle flap reconstruction in a BRCA-2 positive patient. Plast Reconstr Surg. 1999;103(2):548–53.CrossRefPubMed
41.
Albornoz CR, Bach PB, Mehrara BJ, Disa JJ, Pusic AL, McCarthy CM, et al. A paradigm shift in U.S. breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013;131(1):15–23.CrossRefPubMed
42.
Panchal H, Matros E. Current trends in postmastectomy breast reconstruction. Plast Reconstr Surg. 2017;140(5S):7S–13S.CrossRefPubMed
43.
Basta MN, Gerety PA, Serletti JM, Kovach SJ, Fischer JP. A systematic review and head-to-head meta-analysis of outcomes following direct-to-implant versus conventional two-stage implant reconstruction. Plast Reconstr Surg. 2015;136(60):1135–44.CrossRefPubMed
44.
Corban J, Shash H, Safran T, Sheppard-Jones N, Fouda–Neel O. A systematic review of complications associated with direct implant vs. tissue expanders following wise pattern skin-sparing mastectomy. J Plast Reconstr Aesthet Surg. 2017;70(9):1191–9.CrossRefPubMed
45.
Eriksen C, Lindgren EN, Frisell J, et al. A prospective randomized study comparing two different expander approaches in implant-based breast reconstruction: one stage versus two stages. Plast Reconstr Surg. 2012;130(2):254–64.CrossRef
46.
Susarla S, Ganske I, Helliwell L, et al. Comparison of clinical outcomes and patient satisfaction in immediate single-stage versus two-stage implant-based breast reconstruction. Plast Reconstr Surg 2015;135(1):1e–8e.
47.
Boughey JC, Hoskin TL, Harmann LC, et al. Impact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy. Ann Surg Oncol. 2015;22(2):401–8.CrossRefPubMed
48.
Gruber RP, Kahn RA, Lash H, Maser MR, Apfelberg DB, Laub DR. Breast reconstruction following mastectomy: a comparison of submuscular and subcutaneous techniques. Plast Reconstr Surg. 1981;67(3):312–7.CrossRefPubMed
49.
Reitsamer R, Peintinger F. Prepectoral implant placement and complete coverage with porcine acellular dermal matrix: a new technique for direct-to-implant breast reconstruction after nipple-sparing mastectomy. J Plast Reconstr Aesthet Surg. 2015;68(2):162–7.CrossRefPubMed
50.
Woo A, Harless C, Jacobson SR. Revisiting an old place: single-surgeon experience on post-mastectomy subcutaneous implant-based breast reconstruction. Breast J. 2017;23(5):545–53.CrossRefPubMed
51.
Tasoulis MK, Iqbal FM, Cawthorn S, MacNeill F, Vidya R. Subcutaneous implant breast reconstruction: time to consider? Eur J Surg Oncol. 2017;43(9):1636–46.CrossRefPubMed
Metadata
Title
Breast Reconstruction in the Setting of Surgical Prevention for Breast Cancer
Authors
Candice M. Leach
Meredith S. Collins
Publication date
01-09-2018
Publisher
Springer US
Published in
Current Breast Cancer Reports / Issue 3/2018
Print ISSN: 1943-4588
Electronic ISSN: 1943-4596
DOI
https://doi.org/10.1007/s12609-018-0283-x

Other articles of this Issue 3/2018

Current Breast Cancer Reports 3/2018 Go to the issue

Risk and Prevention (ME Wood, Section Editor)

Lifestyle Interventions for Breast Cancer Prevention

Global Breast Cancer (BO Anderson and C Duggan, Section Editors)

Breast Cancer Disparities Among Women in Underserved Communities in the USA

Global Breast Cancer (BO Anderson and C Duggan, Section Editors)

Breast Cancer Diagnosis and Treatment in Low- and Mid-Resource Settings: the Role of Resource-Stratified Clinical Practice Guidelines

Global Breast Cancer (BO Anderson and C Duggan, Section Editors)

Access to Affordable Breast Cancer Care in Eastern Europe

Global Breast Cancer (BO Anderson and C Duggan, Section Editors)

Breast Cancer Disparities Among Women in Low- and Middle-Income Countries

Global Breast Cancer (BO Anderson and C Duggan, Section Editors)

The Role of Quality Measures in Improving Breast Cancer Care in Low-Income Countries
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits